EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy

BACKGROUND: Epidermal growth factor (EGF) and its receptor (EGFR) are part of an important signaling pathway that is involved in the pathogenesis of squamous cell carcinoma of the head and neck (SCCHN). We hypothesized that EGF/EGFR genetic polymorphisms might have a prognostic impact on disease-fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Nai-Wen, Leu, Yi-Shing, Lee, Jehn-Chuan, Liu, Chung-Ji, Cheng, Chieh-Yuan, Lin, Jiun-Sheng, Chen, Yu-Jen, Chen, Chi-Kuan, Fang, I-Chih, Hsieh, Ruey-Kuen, Chang, Yi-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259259/
https://www.ncbi.nlm.nih.gov/pubmed/25506224
http://dx.doi.org/10.2147/OTT.S70188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259259/
https://www.ncbi.nlm.nih.gov/pubmed/25506224
http://dx.doi.org/10.2147/OTT.S70188

Ejemplares similares